Activated K-RAS and its effect on morphological appearance

Journal of Biochemistry

Volumn 156, Issue 3, 2014, Pages 137-145

  Kiyokawa, Etsuko ^a   Minato, Hiroshi ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adenocarcinoma; Lumen; Malignant; Mucin production; Pathology

Indexed keywords

MUCIN; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN;

CANCER INCIDENCE; CANCER PROGNOSIS; CELL COMMUNICATION AND CELL CONTACT; CELL DENSITY; CELL PROLIFERATION; COLON CANCER; CONTACT INHIBITION; DOWN REGULATION; FIBROBLAST; GENE MUTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MDCK CELL LINE; METAPLASIA; NONHUMAN; ONCOGENE K RAS; OVARY CANCER; PANCREAS CANCER; REVIEW; SIGNAL TRANSDUCTION; THYROID CANCER; TUMOR MICROENVIRONMENT; ANIMAL; BIOLOGICAL MODEL; CELL TRANSFORMATION; ENZYME ACTIVATION; GENETICS; METABOLISM; MUTATION; NEOPLASM; PATHOLOGY;

ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; HUMANS; MODELS, GENETIC; MUTATION; NEOPLASMS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 84907351053     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvu041     Document Type: Review

References (59)

1. Ostrem, J.M., Peters, U., Sos, M.L., Wells, J. A., and Shokat, K.M. (2013) K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature 503, 548-551
2. Zimmermann, G., Papke, B., Ismail, S., Vartak, N., Chandra, A., Hoffmann, M., Hahn, S.A., Triola, G., Wittinghofer, A., Bastiaens, P.I.H., and Waldmann, H. (2013) Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling. Nature 497, 638-642
3. Bryant, K.L., Mancias, J.D., Kimmelman, A.C., and Der, C.J. (2014) KRAS: feeding pancreatic cancer proliferation. Trends Biochem. Sci. 39, 91-100
4. Pylayeva-Gupta, Y., Grabocka, E., and Bar-Sagi, D. (2011) RAS oncogenes: weaving a tumorigenic web. Nat. Rev. Cancer 11, 761-774
5. Stephen, A.G., Esposito, D., Bagni, R.K., and McCormick, F. (2014) Dragging Ras back in the ring. Cancer Cell 25, 271-281
6. Santos, E., Martin-Zanca, D., Reddy, E.P, Pietti, M.A., Della, P.G., and Barbacid, M. (1984) Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science 223, 661-664
7. Bos, J.L. (1989) ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689
8. Johnson, L., Mercer, K., Greenbaum, D., Bronson, R.T., Crowley, D., Tuveson, D. A., and Jacks, T. (2001) Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410, 1111-1116
9. Guerra, C., Mijimolle, N., Dhawahir, A., Dubus, P., Barradas, M., Serrano, M., Campuzano, V., and Barbacid, M. (2003) Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4, 111-120
10. Ray, K.C., Bell, K.M., Yan, J., Gu, G., Chung, C.H., Washington, M.K., and Means, A.L. (2011) Epithelial tissues have varying degrees of susceptibility to KrasG12D-initiated tumorigenesis in a mouse model. PLoS One 6, e16786
11. Brune, K., Abe, T., Canto, M., O'malley, L., Klein, A., Maita, A., Adsay, N.V., Fishman, E.K., Cameron, J., Yeo, C.J., Kern, S.E., Goggins, M., and Hruban, R.H. (2006) Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am. J. Surg. Pathol. 30, 1067-1076
12. DiGiuseppe, J.A., Hruban, R.H., Offerhaus, G.J., Clement, M.J., van den Berg, F.M., Cameron, J.L., and van Mansfeld, A.D. (1994) Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am. J. Pathol. 144, 889-895
13. Kitamura, H., Kameda, Y., Ito, T., and Hayashi, H. (1999) Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma. Am. J. Clin. Pathol. 111, 610-622
14. McCluggage, W.G. (2011) Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. Pathology 43, 420-432
15. Kopp, J.L., von Figura, G., Mayes, M., Liu, F.F., Dubois, C.L., Pan, F.C., Akiyama, H., Wright, C.V., Jensen, K., Hebrok, M., and Sander, M. (2012) Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 22, 737-750
16. Ringel, J. and Lohr, M. (2003) The MUC gene family: their role in diagnosis and early detection of pancreatic cancer. Mol. Cancer 2, 9
17. Zhu, L., Shi, G.C., Schmidt, M., Hruban, R.H., and Konieczny, S.F. (2007) Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am. J. Pathol. 171, 263-273
18. Shi, G., DiRenzo, D., Qu, C., Barney, D., Miley, D., and Konieczny, S.F. (2013) Maintenance of acinar cell organization is critical to preventing Kras-induced acinarductal metaplasia. Oncogene 32, 1950-1958
19. OBrien, T.R., Padian, N.S., Hodge, T., Goedert, J.J., OBrien, S.J., and Carrington, M. (1998) Loss of the acinar-restricted transcription factor Mist1 accelerates Kras-induced pancreatic intraepithelial neoplasia. Gastroenterology 136, 1368-1378
20. Kadara, H., Kabbout, M., and Wistuba. II (2012) Pulmonary adenocarcinoma: a renewed entity in 2011. Respirology 17, 50-65
21. Yatabe, Y., Borczuk, A.C., Powell, C., and Powell, C.A. (2011) Do all lung adenocarcinomas follow a stepwise progression? Lung Cancer 74, 7-11
22. Jackson, E.L., Willis, N., Mercer, K., Bronson, R.T., Crowley, D., Montoya, R., Jacks, T., and Tuveson, D.A. (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic Kras. Genes Dev. 15, 3243-3248
23. Tuveson, D.A., Shaw, A.T., Willis, N.A., Silver, D., Jackson, E.L., Chang, S., Mercer, K., Mercer, K.L., Grochow, R.F., Hock, H.F., Crowley, D.F., Hingorani, S.R., Zaks, T., King, C.F., Jacobetz, M.A., Wang, L.F., Bronson, R.T., Orkin, S.H., DePinho, R.A., and Jacks, T. (2006) Endogenous oncogenic Kras( G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5, 375-387
24. Maeda, Y., Tsuchiya, T., Hao, H., Tompkins, D.H., Xu, Y., Mucenski, M.L., Du, L., Keiser, A.R., Fukazawa, T., Naomoto, Y., Nagayasu, T., and Whitsett, J.A. (2012) KrasG12D and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung. J. Clin. Invest. 122, 4388-4400
25. Snyder, E.L., Watanabe, H., Magendantz, M., Hoersch, S., Chen, T.A., Wang, D.G., Crowley, D, Whittaker, C.A., Meyerson, M, Kimura, S, and Jacks, T. (2013) Nkx2-1 Represses a latent gastric differentiation program in lung adenocarcinoma. Mol. Cell 50, 185-199
26. Rosty, C., Young, J.P., Walsh, M.D., Clendenning, M., Walters, R.J., Pearson, S., Pavluk, E., Nagler, B., Pakenas, D., Jass, J.R., Jenkins, M.A., Win, A. K., Southey, M.C., Parry, S., Hopper, J.L., Giles, G.G., Williamson, E., English, D.R., and Buchanan, D.D. (2013) Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features. Mod. Pathol. 26, 825-834
27. Pulciani, S., Santos, E., Lauver, A.V., Long, L.K., Robbins, K.C., and Barbacid, M. (1982) Oncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells. Proc. Natl Acad. Sci. U.S.A. 79, 2845-2849
28. Parada, L.F., Tabin, C.J., Shih, C., and Weinberg, R.A. (1982) Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 297, 474-478
29. Der, C.J., Krontiris, T.G., and Cooper, G.M. (1982) Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc. Natl Acad. Sci. U.S.A. 79, 3637-3640
30. Noda, M., Selinger, Z., Scolnick, E.M., and Bassin, R.H. (1983) Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes. Proc. Natl Acad. Sci. U.S.A. 80, 5602-5606
31. Noda, M., Kitayama, H., Matsuzaki, T., Sugimoto, Y., Okayama, H., Bassin, R.H., and Ikawa, Y. (1989) Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes. Proc. Natl Acad. Sci. U.S.A. 86, 162-166
32. Mochizuki, N., Yamashita, S., Kurokawa, K., Ohba, Y., Nagai, T., Miyawaki, A., and Matsuda, M. (2001) Spatio-temporal images of growth-factor-induced activation of Ras and Rap1. Nature 411, 1065-1068
33. Nishioka, T., Frohman, M.A., Matsuda, M., and Kiyokawa, E. (2010) Heterogeneity of phosphatidic acid levels and distribution at the plasma membrane in living cells as visualized by a forster resonance energy transfer (FRET) biosensor. J. Biol. Chem. 285, 35979-35987
34. Hall, H.G., Farson, D.A., and Bissell, M.J. (1982) Lumen formation by epithelial cell lines in response to collagen overlay: a morphogenetic model in culture. Proc. Natl Acad. Sci. U.S.A. 79, 4672-4676
35. O'Brien, L.E., Zegers, M.M., and Mostov, K.E. (2002) Opinion: Building epithelial architecture: insights from three-dimensional culture models. Nat. Rev. Mol. Cell Biol. 3, 531-537
36. Sakurai, A., Matsuda, M., and Kiyokawa, E. (2012) Activated Ras protein accelerates cell cycle progression to perturb MDCK cystogenesis. J. Biol. Chem. 287, 31703-31711
37. Hogan, C., Dupre-Crochet, S., Norman, M., Kajita, M., Zimmermann, C., Pelling, A.E., Piddini, E., Baena-Lopez, L. A., Vincent, J.P., Itoh, Y., Hosoya, H., Pichaud, F., and Fujita, Y. (2009) Characterization of the interface between normal and transformed epithelial cells. Nat. Cell Biol. 11, 460-467
38. Wu, S.K., Gomez, G.A., Michael, M., Verma, S., Cox, H.L., Lefevre, J.G., Parton, R.G., Hamilton, N.A., Neufeld, Z., and Yap, A.S. (2014) Cortical F-actin stabilization generates apical-lateral patterns of junctional contractility that integrate cells into epithelia. Nat. Cell Biol. 16, 167-178
39. Slattum, G., Gu, Y., Sabbadini, R., and Rosenblatt, J. (2014) Autophagy in oncogenic K-Ras promotes basal extrusion of epithelial cells by degrading S1P. Curr. Biol. 24, 19-28
40. Montesano, R., Matsumoto, K., Nakamura, T., and Orci, L. (1991) Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67, 901-908
41. Montesano, R., Schaller, G., and Orci, L. (1991) Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell 66, 697-711
42. Montesano, R. and Soulie, P. (2002) Retinoids induce lumen morphogenesis in mammary epithelial cells. J. Cell Sci. 115, 4419-4431
43. Debnath, J. and Brugge, J.S. (2005) Modelling glandular epithelial cancers in three-dimensional cultures. Nat. Rev. Cancer 5, 675-688
44. Jaffe, A.B., Kaji, N., Durgan, J., and Hall, A. (2008) Cdc42 controls spindle orientation to position the apical surface during epithelial morphogenesis. J. Cell Biol. 183, 625-633
45. Liu, J.S., Farlow, J.T., Paulson, A.K., Labarge, M.A., and Gartner, Z.J. (2012) Programmed cell-to-cell variability in Ras activity triggers emergent behaviors during nammary epithelial morphogenesis. Cell Rep. 2, 1461-1470
46. Yan, J., Roy, S., Apolloni, A., Lane, A., and Hancock, J.F. (1998) Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J. Biol. Chem. 273, 24052-24056
47. Marchetti, A., Felicioni, L., Malatesta, S., Grazia Sciarrotta, M., Guetti, L., Chella, A., Viola, P., Pullara, C., Mucilli, F., and Buttitta, F. (2011) Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations. J. Clin. Oncol. 29, 3574-3579
48. Pai, R.K., Jayachandran, P.F., Koong, A.C., Chang, D., Kwok, S., Ma, L.F., Arber, D.A., Balise, R.R., Tubbs, R.R., Shadrach, B.F., and Pai, R.K. (2012) BRAFmutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features. Am. J. Surg. Pathol. 36, 744-752
49. Rivera, M., Ricarte-Filho, J., Knauf, J., Shaha, A., Tuttle, M., Fagin, J.A., and Ghossein, R.A. (2010) Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod. Pathol. 23, 1191-1200
50. Adeniran, A.J., Zhu, Z.F., Gandhi, M.F., Steward, D.L., Fidler, J.P., Giordano, T.J., Biddinger, P.W., and Nikiforov, Y.E. (2006) Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am. J. Surg. Pathol. 30, 216-222
51. O'Brien, L.E., Tang, K., Kats, E.S., Schutz-Geschwender, A., Lipschutz, J.H., and Mostov, K.E. (2004) ERK and MMPs Sequentially regulate distinct stages of epithelial tubule development. Dev. Cell 7, 21-32
52. Lehmann, K., Janda, E., Pierreux, C.E., Rytmaa, M., Schulze, A., McMahon, M., Hill, C.S., Beug, H., and Downward, J. (2000) Raf induces TGFb production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Gene Dev. 14, 2610-2622
53. Pearson, G.W. and Hunter, T. (2007) Real-time imaging reveals that noninvasive mammary epithelial acini can contain motile cells. J. Cell Biol. 179, 1555-1567
54. Pearson, G.W. and Hunter, T. (2009) PI-3 kinase activity is necessary for ERK1/2-induced disruption of mammary epithelial architecture. Breast Cancer Res. 11, R29
55. Guo, J.Y., Karsli-Uzunbas, G., Mathew, R., Aisner, S.C., Kamphorst, J.J., Strohecker, A.M., Chen, G., Price, S., Lu, W., Teng, X., Snyder, E., Santanam, U., DiPaola, R.S., Jacks, T., Rabinowitz, J.D., and White, E. (2013) Autophagy suppresses progression of K-rasinduced lung tumors to oncocytomas and maintains lipid homeostasis. Gene Dev. 27, 1447-1461
56. Imamura, Y., Morikawa, T., Liao, X., Lochhead, P., Kuchiba, A., Yamauchi, M., Qian, Z.R., Nishihara, R., Meyerhardt, J.A., Haigis, K.M., Fuchs, C.S., and Ogino, S. (2012) Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers. Clin. Cancer Res. 18, 4753-4763
57. Rui, Y.Y., Zhang, D., Zhou, Z.G., Wang, C., Yang, L., Yu, Y.Y., and Chen, H.N. (2013) Can K-ras gene mutation be utilized as prognostic biomarker for colorectal cancer patients receiving chemotherapy? A meta-analysis and systematic review. PLoS One 8, e77901
58. Cox, A.D. and Der, C.J. (2003) The dark side of Ras: regulation of apoptosis. Oncogene 22, 8999-9006
59. Grabocka, E., Pylayeva-Gupta, Y., Jones, M.J., Lubkov, V., Yemanaberhan, E., Taylor, L., Jeng, H.H., and Bar-Sagi, D. (2014) Wild-type H- and N-Ras promote mutant K-Ras-driven tumorigenesis by modulating the DNA damage response. Cancer Cell 25, 243-256